Rights and permissions
About this article
Cite this article
Docetaxel-modulated capecitabine feasible for advanced NSCLC. Inpharma Wkly. 1487, 8 (2005). https://doi.org/10.2165/00128413-200514870-00016
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200514870-00016